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Abstract
Background: Ongoing Helicobacter pylori (HP) infection triggers a chronic active gastritis. Eradicating HP reduces gastric
inflammation, but does not eliminate it. We sought to characterize this persistent gastritis, and demonstrate the persistence
of HP-specific Th17 responses in individuals previously infected with HP but who no longer had evidence of ongoing
infection.
Methodology/Principal Findings: Study subjects were divided into 3 groups 55 individuals had active HP infection (group
A), 41 were diagnosed with previous HP infection (group P), and 59 were naı ¨ve to HP (group N). Blood and gastric tissue
were obtained with written informed consent from all subjects, and immune responses were evaluated using flow
cytometry, semi-quantitative real time PCR, immunofluorescent staining, ELISA, and multiplex cytometric bead array for
cytokine quantification. Elevated IL-17A responses were observed in patients from group A compared to group N.
Interestingly, IL-17A responses remained persistently elevated in the blood and gastric mucosa of individuals from group P,
despite the absence of ongoing HP infection. Using purified CD4
+ T cells as effectors and antibodies that blocked antigen
presentation by MHC Class II, we showed that these persistent IL-17A responses were mediated primarily by HP-specific
Th17 cells, rather than other immune cells that have also been described to secrete IL-17A. Gastric mucosal IL-1b levels were
also persistently elevated in group P, and neutralisation of IL-1b reduced the HP-specific IL-17A response of purified CD4
+ T
cells to autologous HP-pulsed antigen presenting cells in vitro, suggesting a functional association between IL-1b and the
persistent Th17 response in group P patients.
Conclusions/Significance: Despite lack of ongoing HP infection, HP-specific Th17 cells persist in the blood and gastric
mucosa of individuals with past HP infection. We speculate that this persistent inflammation might contribute to gastric
mucosal pathology, for example, persistent increased gastric cancer risk despite eradication of HP.
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Introduction
Helicobacter pylori (HP) infects the human stomach, and has been
associated with various gastric diseases, including gastritis, peptic
ulcer disease, gastric adenocarcinoma, and gastric mucosa-
associated lymphoma. [1] Infection of the gastric epithelium is
sensed by Toll-like receptors and NOD-like receptors, and triggers
an inflammatory response characterized by elevated levels of pro-
inflammatory cytokines, e.g. IL-1b, IL-6, IL-8, IL-18, TNF-a, and
the recruitment of neutrophils and lymphocytes into the gastric
mucosa. [2,3,4] Nevertheless, HP evades this vigorous response to
establish a persistent infection that co-exists with chronic active
inflammation of the gastric mucosa. [3].
Gastric mucosal lymphocytes isolated from patients infected
with HP contain increased numbers of CD4
+ T cells that produce
IFNc, consistent with prominent Th1 polarization. [5,6,7] More
recently, ongoing HP infection has also been associated with
upregulation of IL-17A expression in the gastric mucosa. [8,9,10]
IL-17A is the most widely studied member of the IL-17 family of
cytokines (IL-17A – F), and is produced by Th17 CD4
+ T cells as
well as other subsets of immune cells. [11,12] Extracellular
bacterial and fungal infections elicit strong IL-17A responses that
stimulate stromal and epithelial cells to release pro-inflammatory
cytokines and chemokines, e.g. TNF-a, IL-1b, IL-6, CXCL1,
CXCL2, CCL2, CCL7, CCL20, which recruit neutrophils,
macrophages and lymphocytes to the site of infection. [13,14]
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39199IL-17A also induces expression of matrix metalloproteinases 1, 2,
3, 9, and 13, which regulate inflammation by modulating
chemokine activity and establishing chemotactic gradients. [15]
On the other hand, pathological persistence of IL-17A responses
has been associated with tissue damage in the setting of chronic
inflammatory and autoimmune diseases. [12,14] IL-17A has also
been implicated in the pathogenesis of various cancers, [16,17,18]
including gastric cancer, [19,20] although the biological basis of
this association remains unclear.
Even though HP eradication is now possible with the use of
antimicrobial agents, [21] significant lymphocytic infiltrate can
remain in the gastric mucosa more than a decade following
successful treatment of HP infection. [22] However, this chronic
lymphocytic infiltrate has not been further characterized. Since
chronic IL-17A signaling has pathological associations, we wanted
to determine whether IL-17A responses contribute to persistent
gastric inflammation after HP eradication, and the types of
immune cells that produced IL-17A under these conditions.
Previous studies identified upregulated IL-17A expression
during HP infection by comparing individuals with ongoing HP
infection versus ‘‘HP negative’’ (uninfected, or naive) individuals.
[8,10] In this study, the association between IL-17A and HP
infection was re-evaluated by also including patients with past HP
infection in the comparison. These were individuals without
evidence of ongoing HP infection or gastric cancer, but who either
had a past history of treatment for HP infection or tested
seropositive for HP. By studying such individuals, persistent HP-
specific Th17 responses were detected in the blood and gastric
mucosa despite absence of ongoing HP infection. These responses
were associated with elevated IL-1b levels in the gastric mucosa.
Materials and Methods
Patient Samples and Classification
This research was conducted according to the principles
expressed in the Declaration of Helsinki, and was approved by
the Centralized Institutional Review Board (CIRB), Singapore
Health Services, Singapore. Peripheral blood and gastric biopsy
samples were obtained with written informed consent from 155
patients who underwent gastroscopy at the Singapore General
Hospital (patient data summarized in table 1). Patients were asked
to stop proton pump inhibitors and antibiotics 2 weeks and 4
weeks prior to endoscopy respectively. For each patient, biopsies
were obtained from the gastric antrum, incisura, body, and cardia.
Six of these biopsy samples were sent for histological assessment
with hematoxylin and eosin stain, one for rapid urease test, and
two samples were cultured for HP. Patients were classified as
having ‘Active’ infections (Group A) if HP was identified in
histology, rapid urease test, or culture. Patients without evidence of
active HP infection but who either had a past history of treatment
for HP infection, or who tested seropositive for HP, were classified
as having ‘Past’ infection (Group P). [23] The HP serological status
was determined by an immunoblot assay, Helicoblot 2.1 (MP
Biomedicals, Singapore). ‘Naive’ patients (Group N) had no
evidence of either an active or past HP infection. Pre-cancerous
lesions were defined as the presence of either chronic atrophic
gastritis or intestinal metaplasia in gastric biopsy samples that had
been sent for histological assessment.
Isolation and Culture of Peripheral Blood Mononuclear
Cells (PBMCs)
PBMCs were obtained from whole blood by density centrifu-
gation on a Ficoll-Hypaque (GE Healthcare) gradient. RPMI-10
used for all cell cultures consisted of RPMI 1640 (Hyclone), 10%
fetal calf serum (Hyclone), and l-glutamine, penicillin/streptomy-
cin and sodium pyruvate (Gibco) added according to the
manufacturers’ recommendations. CD4
+ T cells were selected by
positive selection (Miltenyi Biotec), and kept in RPMI-10
supplemented with 50 U/ml IL-2 (eBioscience) overnight before
co-culture with antigen presenting cells.
Isolation and Expansion of Lamina Propria Mononuclear
Cells (LPMCs)
Gastric biopsy samples were mechanically disrupted in a small
volume of RPMI, centrifuged at 500 g, and clarified supernatant
was collected for multiplex cytokine array analyses. The remaining
tissue was digested and then placed in culture for 24 hours. Non-
adherent cells containing LPMCs were collected, washed, and co-
cultured with irradiated (40 Gy) allogeneic feeder cells (5 feeders :
1 LPMC) in 96-well plates containing RPMI-10 supplemented
with 1 mg/ml phytohemagglutinin (PHA) (Sigma) and 200 U/ml
IL-2. These cultures were stimulated with PHA and fresh
allogeneic feeders every 7–8 days for 3 cycles, then harvested for
assays.
HP Lysate and Antigen-pulsing
Lysate from HP strain 26695 was prepared by sonication and
used at 10 mg/ml for all assays. PBMCs used as antigen-presenting
cells (APCs) in co-culture assays were pulsed for 24 hours with
lysate and irradiated at 40 Gy prior to co-culture. Purified no
azide low-endotoxin mouse anti-human HLA-DR, DP, DQ
antibody (Becton Dickinson, clone Tu ¨39) was used to block
antigen presentation by MHC Class II. In some experiments,
recombinant human IL-1 receptor antagonist (R&D Systems) was
used at a final concentration of 200 ng/ml to block the activity of
IL-1b in culture.
Intracellular Staining and Flow Cytometry
PBMCs were stimulated for 5 hours in RPMI-10 with 1 mM
phorbol 12-myristate 13-acetate (PMA) (Sigma), 1 mg/ml iono-
mycin (Sigma), and Golgistop (BD Pharmingen), then fixed and
permeabilised (Cytofix/Cytoperm kit, Becton Dickinson), and
stained with anti-IL-17A-FITC, anti-CCR6-PE, anti-CD3-PE-
Table 1. Patient data.
All
Active HP infection
(Group A) Past HP infection (Group P) Naı ¨ve (Group N)
n 155 55 41 59
Mean age in years 6 SD 55612 56611 59695 1 613
Numbers of male subjects (% of male
subjects in the respective groups)
70 (46%) 34 (62%) 18 (44%) 19 (32%)
doi:10.1371/journal.pone.0039199.t001
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cytometry was performed on a CyAN analyzer (Beckmann
Coulter). CD4
+ T cells were gated as CD3
+CD8
2 events because
cell surface expression of CD4 is downregulated during stimulation
of PBMCs with PMA and ionomycin, which makes it difficult to
unambiguously identify CD4
+ T cells using CD4 as a cell marker.
Immunofluorescent Staining of Frozen Sections
Antral biopsies were snap frozen in Tissue-Tek O.C.T.
compound (Sakura Finetek) and stored at 280uC. 5 mm sections
were cut, fixed in ice-cold acetone, and blocked using either PBS
0.5% BSA (Sigma) or a biotin/streptavidin blocking kit (Vector
Labs) according to the manufacturer’s instructions. The following
antibodies were used to stain sections: mouse anti-IL-17A-biotin
(eBioscience), streptavidin-Alexa Fluor 546 (Invitrogen), polyclonal
goat anti-IL-22 (R&D), donkey anti-goat IgG Alexa Fluor 546
(Invitrogen), and mouse anti-CD4 Alexa Fluor 488 (eBioscience).
Antibodies were diluted in PBS containing 0.5% human AB serum
(Sigma) for incubating with sections, and washing was done in
PBS. Sections were counterstained with DAPI before mounting in
fluorescent mounting medium. Samples were imaged with an
AxioCam fluorescent microscope (Zeiss), and images were
analysed using Axiovision LE software (Zeiss).
mRNA Isolation and Real Time PCR
mRNA was isolated from gastric biopsy samples (RNA-Protein
isolation kit, Macherey-Nagel), converted to cDNA (Superscript
III, Invitrogen), and gene expression was evaluated by real time
PCR using SYBR green chemistry. Primers used and their
annealing temperatures have been summarized in table 2. For all
reactions, elongation was carried out at 72uC, and 40 cycles of
amplification were performed.
Cytokine Quantification
HP-specific IL-17A or IFNc levels in culture supernatants, and
IL-22 concentrations in biopsy supernatant samples, were assayed
using ELISA kits (eBioscience). Milliplex xMAP kits (Millipore)
were used to measure all other cytokines.
Statistical Analyses
The Kruskal-Wallis test with Dunn’s multiple comparisons post-
hoc test was used for statistical analyses of data from the 3 patient
groups (Groups A, P, and N). The Mann Whitney U test was used
when making comparisons between two groups of samples. Data
analysis was performed using GraphPad Prism software (Graph-
Pad Software Inc.).
Results
IL-17A Responses Remained Elevated in the Blood and
Gastric Mucosa of Individuals with Evidence of Previous
H. pylori Infection
The frequencies of IL-17A-secreting CD4
+ T cells in PBMCs
that had been stimulated with PMA and ionomycin were





+ (figure 1A). Individuals with
evidence of past HP infection but who no longer had ongoing





+ cells in the blood (median 1.4%,
range 0.3–4.9%) that was statistically different from individuals
who were naive to HP (group N, median 0.8%, range 0.1–2.8%)





+ cells in individuals with active, ongoing HP infection (group
A, median 1.1%, range 0.2–3.2%) were not statistically different





+ cells among CD3
+CD8
2 PBMCs
remained elevated in some individuals from group P even if they
had been treated for HP more than 10 years ago (figure 1C).
Frozen sections prepared from biopsy samples were also examined
by immunofluorescence microscopy to identify CD4
+IL-17A
+ cells
in the gastric mucosa. Representative immunofluorescence micro-
photographs showing samples from group A, group P, and group
N can be found in figures S1A–S1C respectively. Gastric mucosal
CD4
+IL-17A
+ cells were significantly elevated in group P patients
compared to group N (figure 1D). The median number of
infiltrating CD4
+IL-17A
+ cells was 8.0 (range 4.7–15.1) in group
A, 9.3 (range 2.3–20.8) in group P, and 4.9 (range 1.8–11.4) in
group N. Gastric mucosal CD4
+IL-17A
+ cells remained persis-
tently elevated in some individuals from group P even if they had
been treated for HP more than 10 years ago (figure 1E).
Representative microphotographs depicting gastric mucosal sam-
ples obtained from a patient 2–3 years after treatment to eradicate
HP, and from a patient who had received treatment to eradicate
HP.10 years ago can be found in figures S1D and S1E
respectively. IL-17A protein levels were also significantly higher
in gastric biopsy samples from group A (89 pg/ml, range 61–278)
and group P (36 pg/ml, range 15–119), compared to group N
(15 pg/ml, range 0–58) (figure 1F). Group P individuals depicted
in figure 1F were further divided into 2 sub-groups based on the
presence or absence of pre-cancerous changes (PC) on histology:
PC+ individuals had evidence of chronic atrophic gastritis or
intestinal metaplasia in the gastric mucosa, whereas PC2
individuals did not. PC+ individuals in group P tended to have
higher levels of gastric mucosal IL-17A than PC2 individuals,
Table 2. Primers used to perform real time PCR.
Gene target Primer sequence Annealing temperature
CCL20 Forward 59-CTGGCTGCTTTGATGTCAGTG-39 58uC
CCL20 Reverse 59-GCAGTCAAAGTTGCTTGCTGC-39
hBD-2 Forward 59-GCCTCTTCCAGGTGTTTTTG-39 60uC
hBD-2 Reverse 59-GAGACCACAGGTGCCAATTT-39
IL-23p19 Forward 59-GGGACACATGGATCT AAGAG-39 58uC
IL-23p19 Reverse 59-GCAAGCAGAACTGACTGTTG-39
b-actin Forward 59-AAGATGACCCAGATCATGTTTGAGACC-39 58 or 60uC
b-actin Reverse 59-AGCCAGTCCAGACGCAGGAT-39
doi:10.1371/journal.pone.0039199.t002
Th17 Responses Persist in Past HP Infection





+ cells as a function of CD3
+CD8
2 PBMCs was assessed by flow cytometry. PBMCs were activated with PMA and ionomycin for
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possibly due to the small size of the PC2 sub-group (figure 1G).
IFNc is produced by Th1 CD4
+ T cells. The persistence of
IFNc-producing cells in our cohort of patients was also examined.
Frequencies of IFNc+ cells among CD3
+CD8
2 PBMCs following
stimulation with PMA and ionomycin were not significantly
different across groups A, P, and N (figure S2). However, gastric
mucosal IFNc levels were significantly higher in groups A
(173 pg/ml, range 56–399) and P (158 pg/ml, range 41–343)
compared to group N (49 pg/ml, range 0–159) (figure 1H).
Altogether, the observations depicted in figures 1C21H suggest
that gastric mucosal inflammation persists in group P patients
despite the absence of ongoing HP infection, and identify CD4
+IL-
17A
+ cells as a component of this persistent inflammation.
Ongoing HP infection in our cohort of individuals with past
HP infection was excluded on the basis of negative findings in
gastric biopsies sent for histological examination (6 sites), culture
(2 sites) and testing for urease activity (1 site). Despite sampling
multiple independent gastric mucosal sites to arrive at this
conclusion, the apparent persistence of gastric mucosal CD4
+IL-
17A
+ cells in patients from group P might still be due to ongoing
infection with HP at localised sites that were missed during
endoscopy. IL-8 is released during acute gastric mucosal
inflammation associated with ongoing HP infection. [9] Since
this is a diffusible cytokine, we surmised that ongoing HP
infection might be revealed by elevated gastric mucosal levels of
IL-8 even if the actual site of infection was missed during
endoscopic sampling. Increased levels of gastric mucosal IL-8
were observed in group A patients (1250 pg/ml, range 297–
4223) compared to group N (27 pg/ml, range 0–312) (figure 1I).
However, IL-8 levels in samples from group P (65 pg/ml, range
24–171) were significantly lower than samples from group A and
not significantly different than samples from group N. This
suggests that gastric inflammation caused by undiagnosed
ongoing HP infection is an unlikely explanation for the
persistence of CD4
+IL-17A
+ cells that was observed in group P.
Gastric Mucosal IL-22 Levels did not Differ Significantly
Across the Three Groups of Patients
A subset of IL-17A expressing cells also secrete IL-22, a cytokine
that enhances epithelial integrity and regeneration in the gut, but
promotes inflammation under certain experimental settings. [24]
Gastric mucosal IL-22 expression in our patient cohort was
assayed using immunofluorescence microscopy and ELISA. IL-22
expression did not differ significantly among our 3 groups of
patients (figures 2A and 2B). IL-22 has been reported to have
tissue protective as well as pro-inflammatory properties; the
balance between these two activities might be governed by the
extent of IL-22 co-expression with IL-17A. IL-22 in the absence of
IL-17A has tissue-protective effects; however IL-22 and IL-17
synergistically provoke inflammation when co-expressed. [25] As
a measure of cytokine co-expression, the ratio of IL-17A
concentration to IL-22 concentration in the supernatant of
mechanically disrupted gastric biopsy samples was calculated for
individual biopsy samples. IL-17A/IL-22 ratios were significantly
elevated in samples from groups A and P compared to group N
(figure 2C). Co-expression of IL-17A and IL-22 suggests that the
gastric cytokine milieu in group P patients continues to be biased
against the baseline state of mucosal maintenance found in HP-
naı ¨ve patients, despite the absence of ongoing HP infection.
HP-specific Th17 Responses Persist in Patients with
Evidence of Past HP Infection
In order to study HP-specific IL-17A responses, whole lysate of
HP strain 26695 was used to stimulate PBMCs and the responses
were normalised against PBMCs that had not been pulsed with
HP lysate. PBMCs from individuals in group P produced a median
8-fold more IL-17A when stimulated with HP than control
PBMCs from the same individuals that had not been pulsed with
HP lysate (range 1–367), which was significantly higher than the
median 2-fold increase in group N (range 0.9–9) (figure 3A).
PBMCs from group A produced a median 6-fold more IL-17A
when stimulated with HP (range 2–105), but the difference
compared to group N did not reach statistical significance. In
addition to CD4
+ T cells, several other subsets of immune cells
found in PBMCs have been reported to secrete IL-17A, e.g. CD8
+
T cells, NK cells, NKT cells, cd TCR T cells. [26] Instead of
unfractionated PBMCs, the experiment was repeated using
purified CD4
+ T cells as responders to demonstrate that these
cells mediated the persistent HP-specific responses in group P. The
response of a representative patient from group P has been
depicted in figure 3B. Purified CD4
+ T cells co-cultured with HP-
pulsed APCs produced a detectable IL-17A response. This HP-
specific IL-17A response decreased ,3 fold in the presence of
antibody that blocked antigen presentation by MHC Class II
compared to isotype control mouse IgG2a antibody. The
experiment was repeated for a number of individuals from the 3
patient groups, and the results have been summarized in table 3.
IL-17A production was higher in PBMCs from groups A and P
than from group N, and blocking MHC Class II resulted in
decreased IL-17A production.
To demonstrate the persistence of HP-specific Th17 cells in
gastric mucosal samples from patients with past HP infection, the
experiment was performed using gastric LPMCs as responders.
5 hours in the presence of GolgiStop. Cells were stained for cell surface CD3, CD8, and CCR6, fixed, permeabilised, and stained for intracellular IL-17A.
Th17 cells were defined as CCR6
+IL-17A
+ events within the CD3
+CD8
2 compartment. Representative flow cytometry plots of individuals from group




+ cells as a percentage of CD3
+CD8
2 cells among PBMCs that had been
stimulated with PMA and ionomycin. Group A (n=44), group P (n=47), and group N (n=48). The median and interquartile ranges have been




+ events within the CD3
+CD8
2 compartment for
individuals from group P divided according to years since HP treatment. 1 year (n=13), 2–3 years (n=9), 4–9 years (n=7), and $10 years (n=3). (D)
Number of CD4
+IL-17A
+ cells per high powered field (HPF) in gastric biopsy samples. Immunofluorescence microscopy was performed on gastric
biopsies obtained from 8 patients in group A, 17 patients in group P, 12 patients in group N. For each patient sample, ten HPFs were evaluated and
the average number of CD4
+IL-17A
+ cells per HPF was represented on the scatter plot. (E) Number of CD4
+IL-17A
+ cells per HPF in samples from
group P stratified according to years since HP treatment. 1 year (n=3), 2–3 years (n=5), 4–9 years (n=1), and $10 years (n=3). (F 2 I) Cytokine
concentrations in clarified homogenate obtained from mechanically disrupted gastric biopsy samples were measured using the MILLIPLEXH xMAPH
bead-based cytokine quantification assay. (F) IL-17A concentration in gastric biopsy samples obtained from patients in group A (n=7), group P
(n=15), and group N (n=9). (G) IL-17A concentration in gastric biopsy samples from group P individuals depicted in (F) who were further sub-
grouped based on the presence (PC+) or absence (PC2) of histological evidence of pre-cancerous lesions (chronic atrophic gastritis or intestinal
metaplasia) in the gastric mucosa. PC+ (n=12), PC2 (n=3). (H) IFNc concentration in gastric biopsy samples obtained from patients in group A
(n=7), group P (n=15), and group N (n=9). (I) IL-8 concentration in gastric biopsy samples obtained from patients in group A (n=7), group P
(n=15), and group N (n=9). NS: not significant, *p,0.05, **p,0.001, ***p,0.0001.
doi:10.1371/journal.pone.0039199.g001
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biopsy samples, it was necessary to expand gastric LPMCs for 3
weeks before sufficient cells for our assays could be obtained. The
IL-17A response of a representative patient from group P has been
depicted in figure 3C. LPMCs stimulated with autologous HP-
pulsed APCs released IL-17A into culture supernatant. In the
presence of antibody that blocked antigen presentation by MHC
Class II, this LPMC response decreased to undetectable levels
(limit of detection: 4 pg/ml). The experiment was repeated for
several individuals from groups A, P, and N, and the results have
been summarized in table 4. Levels of IL-17A well above the limit
of detection for the ELISA were observed when LPMCs from
group A or group P were co-cultured with autologous HP-pulsed
APCs, and MHC Class II blockade reduced the production of IL-
17A.
In summary, we observed the persistence of HP-specific, IL-
17A-producing CD4
+ T cells that were restricted by MHC Class II
among PBMCs as well as LPMCs derived from group P samples.
Since the other known cellular sources of IL-17A are not restricted
by MHC Class II, [26] these results suggest that the persistent IL-
17A responses in individuals from group P are mainly mediated by
Th17 cells.
Gastric Mucosal IL-1b Levels Remain Elevated in Patients
with Past HP Infection
To identify factors responsible for the persistence of Th17 cells
in the gastric mucosa of group P patients, expression levels of
cytokines related to the generation, maintenance, or recruitment
of Th17 cells were assessed. CCL20 is a ligand for the chemokine
receptor CCR6, which is expressed on Th17 cells. [27,28]
Consistent with previous reports, [29,30] CCL20 gene expression
was significantly elevated in the gastric mucosa of patients with
ongoing HP infection (figure 4A). However, CCL20 gene
expression was not significantly increased in group P, suggesting
that recruitment of CCR6
+ Th17 cells into the gastric epithelium
by CCL20 was not responsible for the persistence of gastric
infiltrating Th17 cells in this group. Human b-defensin-2 (hBD-2)
can serve as an alternative ligand for CCR6. [31,32] However,
gastric mucosal mRNA levels of hBD-2 were also not significantly
elevated in group P, but only in group A (figure 4B). IL-23 is
important for the maintenance of human Th17 cells. [12]
Although gene expression of IL-23p19 was significantly higher in
group A compared to group N, it was not significantly increased in
gastric mucosal samples from group P (figure 4C). The pro-
inflammatory cytokines IL-6 and TNF-a are important for the
differentiation of Th0 cells into Th17 cells. [12] Significantly
higher concentrations of these cytokines were only observed in
gastric mucosal samples from group A compared to group N, but
not in group P (figures 4D and 4E). IL-1b influences the biology of
Figure 2. IL-22 expression in the gastric mucosa. (A) Number of
IL-22
+ cells per high powered field (HPF) in gastric biopsy samples.
Immunofluorescence microscopy was performed on gastric biopsies
obtained from 13 patients in group A, 20 patients in group P, and 9
patients in group N. Ten HPFs were evaluated per sample, and the
average number of IL-22
+ cells per HPF was represented on the scatter
plot. (B) Ex vivo concentration of IL-22 in gastric biopsies. Cytokine
concentrations in clarified homogenate obtained from mechanically
disrupted gastric biopsy samples were measured by ELISA. Group A
(n=8), group P (n=17), and group N (n=9). (C) The ratio of gastric
mucosal IL-17A to IL-22 was determined by dividing the concentration
of IL-17A in gastric mucosal homogenate with the concentration of IL-
22 found in the same biopsy sample obtained from a given individual.
Group A (n=7), group P (n=14), and group N (n=8). NS: not significant,
*p,0.05, ***p,0.0001.
doi:10.1371/journal.pone.0039199.g002
Th17 Responses Persist in Past HP Infection
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and proliferation of these cells. [34] IL-1b also stimulates the
release of IL-17A by Th17 cells. [35] Interestingly, significantly
higher concentrations of IL-1b were observed in gastric biopsy
samples from both group A and group P compared to group N
(figure 4F). In the same samples, concentrations of IL-1 receptor
antagonist (IL-1Ra) were ,100 fold higher than IL-1b, but did not
differ significantly across the 3 groups (figure 4G). To determine
whether there was a functional association between IL-1b and the
Th17 response, the experiment depicted in figure 3B was repeated
using recombinant IL-1Ra to neutralise the biological activity of
IL-1b. Purified CD4
+ T cells from a group P individual produced
less IL-17A when co-cultured with autologous HP-pulsed APCs in
the presence of IL-1Ra (figure 4H). This suggests that the action of
IL-1b is important for secretion of IL-17A by H. pylori-specific
CD4
+ T cells, and that IL-1b plays a functional role in the
persistent Th17 response observed in group P patients.
Discussion
Previous studies have demonstrated the persistence of gastric
inflammation following HP eradication in an animal model, [36]
as well as in humans. [22] Other studies have shown that IL-17A
responses are present during ongoing HP infection, although the
nature of these IL-17A producing cells was not characterized.
Based on the findings presented in this study, we conclude that IL-
17A responses persist in individuals with past HP infection, and
are mediated largely by Th17 cells.
In order to perform this study, individuals with past but not
ongoing HP infection were identified. Individuals so classified had
either a history of treatment to eradicate HP, or tested seropositive
for HP. These individuals were also carefully screened to exclude
ongoing HP infection. The gastric epithelium of each individual
was sampled at nine independent sites (antrum, incisura, body,
and cardia), and biopsies were sent to exclude the presence of HP
by several methods (6 samples were sent for histology, 2 for
culture, and 1 for urease test). Gastric mucosal levels of IL-8 were
also assayed, since this is a diffusible cytokine that is released
during ongoing HP infection. The low levels of IL-8 observed in
group P, comparable to levels in group N (figure 1I), suggest that
individuals from group P were not likely to harbour ongoing HP
infection at localised sites in the stomach that were inadvertently
missed during endoscopic sampling. Based on these criteria, we
concluded that the individuals in group P did not have ongoing
HP infection at the time of sampling for our study.
Individuals from group P showed persistent IL-17A responses
mediated by MHC Class II-restricted CD4
+ T cells that were
specific for HP, despite absence of ongoing HP infection. Previous
studies have shown that lymphocytes persist in the gastric
Figure 3. Persistent HP-specific Th17 responses in individuals
with past HP infection. (A) The IL-17A response of PBMCs to HP
lysate. 2610
6 PBMCs from the three groups of patients in this study
were incubated for 72 hours in a 96-well plate, together with 10 mg/ml
whole bacterial lysate prepared from HP strain 26695. Subsequently,
culture supernatant was harvested and assayed for IL-17A production
by ELISA. The fold increase in IL-17A production is depicted, i.e.
(cytokine concentration in wells containing PBMCs stimulated with HP
lysate) 4 (cytokine concentration in control wells containing unstimu-
lated PBMCs). Group A (n=7), group P (n=17), and group N (n=10). NS:
not significant, *p,0.05. (B) The HP-specific IL-17A response of CD4
+ T
cells purified from PBMCs. PBMCs were pulsed with HP strain 26695
lysate for 24 hours, and then irradiated at 40 Gy. These cells were used
as APCs, and co-cultured for 48 hours with purified autologous CD4
+ T
cells at a ratio of 5 APC: 1 CD4
+ T cell. In wells where MHC class II
blocking antibody (10 mg/ml) was used, antibody was incubated with
APCs for 1 hour prior to addition of responder CD4
+ T cells. In control
wells, APCs were incubated with an equal concentration of mouse
IgG2a isotype control antibody for the same length of time. IL-17A
levels in culture supernatant were measured using ELISA. The response
from one representative group P patient has been depicted. (C) The HP-
specific IL-17A response of gastric mucosal LPMCs. HP-pulsed PBMCs
were prepared as in (B) for use as APCs. Autologous LPMCs expanded
from gastric biopsy samples were used as responders, and IL-17A levels
in culture supernatant were measured by ELISA after 48 hours of co-
culture. The response from one representative group P patient has
been depicted.
doi:10.1371/journal.pone.0039199.g003
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infection, [36] as well as in humans. [22] We have extended
previous findings by demonstrating that IL-17A responses
contribute to chronic gastric inflammation in individuals with
past HP infection, and this is primarily due to the persistence of
HP-specific Th17 cells (figures 1D and 3C). Since several different
immune cell types can secrete IL-17A, [26] it was necessary to
identify Th17 cells as the main cells responsible for the persistent
IL-17A responses. Th17 cells in frozen sections of gastric
epithelium were identified as cells that stained for both CD4 and
IL-17A (figure 1D). Purified autologous CD4
+ T cells were used as
effectors in the assay depicted in figure 3B, and blocking antibodies
were used to demonstrate that the responses were restricted by
MHC Class II. MHC Class II restriction of IL-17A responses was
also demonstrated for the LPMC experiment depicted in figure 3C.
Based on these results, we conclude that Th17 cells are the main
producers of IL-17A in the blood and lamina propria of
individuals with active HP infection as well as those with past
HP infection, although we cannot exclude a minor contribution
from cells that are not restricted by MHC Class II, e.g. CD8
+ T
cells, cd TCR T cells, NK cells, or NKT cells. These cells might be
responsible for the small residual IL-17A responses that remained
after MHC Class II blockade (figure 3B).
It is unclear whether these persistent Th17 responses simply
represent the activity of effector memory T cells that persist by
homeostatic proliferation following HP clearance. This might be
addressed by an in depth assessment of cellular phenotype (e.g.
CD45RA, CD45RO, CD62L, CD27, CD28, CCR6, etc).
However, in an animal model where timed eradications were
performed following HP infection, eradication of HP after 4 weeks
of infection resulted in the absence of persistent gastric lympho-
cytic infiltrate whereas persistent lymphocytic infiltrate was
observed when HP was eradicated after 8 weeks of infection.
[36] Since effector memory T cells should have developed in both
scenarios, the development of detectable persistent inflammation
only after more prolonged infection suggests that factors in
addition to homeostatic proliferation may be triggered to maintain
gastric LPMCs during chronic HP infection. Once activated, we
speculate that these mechanisms might persist following HP
eradication and continue to support gastric inflammation in the
absence of HP antigen. We explored possible mechanisms that
might maintain gastric mucosal Th17 responses. Continual
migration of lymphocytes from blood into the gastric epithelium
might maintain Th17 numbers in the gastric epithelium. However,
gastric epithelial expression of CCL20 and hBD-2, both chemo-
tactic ligands for CCR6 that is expressed on Th17 cells, was not
elevated in biopsy samples from group P (figures 4A and 4B). Th17
cells might be maintained by IL-23, or by their continual
differentiation from Th0 cells driven by exposure to IL-1b, IL-6,
TNF-a, and TGF-b. [12] Levels of IL-23p19, IL-6, and TNF-
a were not significantly elevated in individuals with past HP
infection (figures 4C–4E). Expression of TGF-b was high and not
significantly different across all 3 groups of individuals (data not
shown). However, IL-1b protein levels remained significantly
elevated in the gastric mucosa of individuals from group P
(figures 4F). We speculate that the presence of IL-1b in the gastric
environment might favor low-level proliferation of Th17 cells
previously recruited into the gastric mucosa during active HP
infection, [34] and so maintain the presence of Th17 cells even
after resolution of HP infection. Alternatively, IL-1b has been
shown to trigger the release of IL-17A by Th17 cells. [35]
Consistent with these hypotheses, neutralization of IL-1b with
recombinant human IL-1Ra reduced the HP-specific IL-17A
response of purified CD4
+ T cells to autologous HP-pulsed APCs
in a 48 hour co-culture assay (figure 4H). Polymorphisms in IL1B
or IL1RN genes that increase circulating levels of IL-1b have been
linked to the development of HP-associated disease, [37,38]
although the mechanism for this association remains unclear. We
Table 3. The IL-17A response of CD4
+ PBMCs to HP-pulsed APCs.
Active Past Naive
IL-17A production per 10
6 CD4
+ T cells (pg/ml) 25946686, n=3 25766629, n=8 4316137, n=3
Mean fold-decrease in the presence of MHC
class II blocking antibody
260.3 5631 60.3
The mean 6 SEM (standard error of mean) has been depicted for measurements of IL-17A concentration in the supernatant of co-culture experiments performed as
described in the legend for figure 3B. CD4
+ T cells were co-cultured with autologous HP-pulsed APCs either in the absence or presence of MHC Class II blocking
antibody. The fold-decrease in response was calculated by dividing the supernatant concentration of IL-17A from the culture without MHC Class II blockade, by the IL-
17A concentration in the culture with MHC Class II blockade. The mean fold-decrease was obtained for the indicated number of biological replicates in each group, and
mean 6 SEM has been reported in the table.
doi:10.1371/journal.pone.0039199.t003
Table 4. The IL-17A response of expanded LPMCs to HP-pulsed APCs.
Active Past Naive
Mean IL-17A production per 10
6 LPMCs
(pg/ml)
8606546, n=3 169638, n=4 1868, n=4
Mean fold-decrease in the presence of MHC
class II blocking antibody
8056581 73641 1467
The mean 6 SEM (standard error of mean) has been depicted for measurements of IL-17A concentration in the supernatant of co-culture experiments performed as
described in the legend for figure 3C. LPMCs were co-cultured with autologous HP-pulsed APCs, either in the absence or presence of MHC Class II blocking antibody.
The fold-decrease in response was calculated by dividing the supernatant concentration of IL-17A from the culture without MHC Class II blockade, by the IL-17A
concentration in the culture with MHC Class II blockade. The mean fold-decrease was obtained for the indicated number of biological replicates in each group, and
mean 6 SEM has been reported in the table.
doi:10.1371/journal.pone.0039199.t004
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e39199Figure 4. Gastric mucosal expression of cytokines that modulate Th17 responses. (A) Semi-quantitative real-time PCR was used to
determine gene expression of CCL20 in gastric biopsy samples, normalised to expression of b-actin. Group A (n=17), group P (n=27), group N
(n=20). (B) Semi-quantitative real-time PCR was used to determine gene expression of hBD-2 in gastric biopsy samples, normalised to expression of
b-actin. Group A (n=16), group P (n=11), and group N (n=12). (C) Semi-quantitative real-time PCR was used to determine gene expression of IL-
23p19 in gastric biopsy samples, normalised to expression of b-actin. Group A (n=15), group P (n=31), and group N (n=30). (D – G) Ex vivo protein
concentrations of IL-6, TNF-a, IL-1b, and IL-1Ra in homogenised gastric biopsy samples were measured by MILLIPLEXH xMAPH bead-based cytokine
quantification assay. Group A (n=6), group P (n=14), and group N (n=7). (H) IL-1 receptor antagonist blocks IL-17A production by CD4
+ T cells co-
cultured with HP-pulsed APCs. PBMCs obtained from a group P individual were pulsed with HP and prepared as in figure 3B for use as APCs. These
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increase chronic inflammation in the gastric mucosa caused by
Th17 cells. Nevertheless, the factors that persistently upregulate
IL-1b expression in the gastric mucosa despite lack of ongoing HP
infection remain unresolved. IL-17A itself can stimulate the release
of IL-1b, although this occurs in the setting of acute inflammation
associated with secretion of other pro-inflammatory cytokines, e.g.
IL-6, IL-8, TNF-a, [12] and has not been reported for chronic
inflammation. Gastric mucosal levels of IL-1Ra, which acts as an
antagonist for IL-1b, were not significantly different across our
three groups of patients (figure 4G).
Experimental evidence from animal models, [36] as well as
epidemiological evidence from follow-up studies in humans,
[39,40] suggest that the risk of developing gastric adenocarcinoma
is not completely eliminated after HP eradication. We speculate
that our findings might relate to this persistent risk of cancer.
Accumulating evidence implicates IL-17A and Th17 responses in
the pathogenesis of gastric cancer. The IL-17A G197A allele has
been associated with elevated IL-17A secretion and increased risk
of cancer. [41] A different study reported that the A7488G
polymorphism in IL-17F, another cytokine in the IL-17 family,
was more highly associated with elevated risk of gastric cancer.
[42] Higher frequencies of Th17 cells have been observed in the
blood of gastric cancer patients compared with healthy controls,
and the proportion of Th17 cells increased with cancer stage in the
blood as well as within tumor-draining lymph nodes. [43] The
frequency of Th17 cells was significantly elevated in tumor-
infiltrating lymphocytes derived from early gastric cancer samples
compared with normal gastric mucosa. [20] Furthermore, in-
creased angiogenesis has been associated with high gene expres-
sion of IL-17A in gastric tumors. [19] When placed in the context
of these reports, our study fills a gap in the literature concerning
the timeline of Th17 responses during HP infection. Elevated
Th17 responses may not be a late manifestation of gastric cancer,
but are perhaps a direct continuation of persistent HP-specific
Th17 responses that may contribute to the pathogenesis of gastric
cancer from early in the timeline of HP infection. Our results
suggest that even after eradication of HP, these Th17 responses
might persist. Individuals from group P with pre-cancerous
histological lesions in the gastric mucosa had higher persistent
levels of IL-17A than group P individuals without pre-cancerous
lesions, although this difference was not statistically significant
(figure 1G). We hypothesise that chronic IL-17A signaling may
promote carcinogenesis, perhaps in synergy with co-expressed IL-
22 (figure 2C), by driving persistent expression of anti-microbial
peptides and matrix metalloproteinases in the gastric mucosa.
[12,24] Elevated expression of these IL-17A target genes facilitates
epithelial-mesenchymal transition, [44,45] and has been associated
with poor prognosis in gastric cancer. [46,47] Ongoing experi-
ments are underway to determine whether IL-17A and IL-22 co-
signaling regulates gene expression in ways relevant to the
pathology of HP-associated disease. We speculate that in addition
to the eradication of HP infection, pharmacological suppression of
gastric mucosal Th17 responses, perhaps by IL-1b blockade,
might also prove helpful for preventing the long-term complica-
tions of HP infection.
Supporting Information
Figure S1 Representative immunofluorescence micro-
photographs. Immunofluorescence microscopy was performed
on gastric mucosal samples that had been stained for CD4, IL-
17A, and DAPI. Representative microphotographs of samples
from (A) group A, (B) group P, and (C) group N. Representative
microphotographs of samples obtained from (D) a patient 2–3
years after treatment to eradicate H. pylori, and (E) from a patient
who had received treatment to eradicate H. pylori infection .10
years ago. White arrows on the merged microphotographs indicate
CD4+IL-17A+ cells.
(TIF)
Figure S2 Percentage of IFNc+ cells among CD3+CD82
cells following stimulation of PBMCs with PMA and
ionomycin. PBMCs were activated with PMA and ionomycin
for 5 hours in the presence of Golgistop, stained for cell surface
CD3 and CD8, fixed, permeabilised, stained for intracellular
IFNc, and analysed using flow cytometry. (A – C) Cells have been
gated on CD3+CD82 events. The FACS plots depict the IFN?
response among CD3+CD82 T cells of representative patients
from groups A, P, and N respectively. (D) Summary of data points
from all patient samples analysed: group A (n=37), group P
(n=44), and group N (n=40). NS: not significant.
(TIF)
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